SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, based in Denver, CO, is a groundbreaking healthcare company dedicated to transforming treatments for critically ill patients facing organ failure. Their patented Selective Cytopheretic Device (SCD) therapy targets hyperinflammatory responses, aiming to improve patient outcomes and save lives in life-threatening conditions such as acute kidney injury due to sepsis.
With the recent FDA approval of their product QUELIMMUNE SCD-PED for pediatric patients, SeaStar Medical is at the forefront of innovative solutions in the medical field. The company is currently conducting pivotal trials for adult patients with acute kidney injury, addressing a significant unmet need in critical care medicine.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.